NEUROENDOCRINE TUMOR
Clinical trials for NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cancers: immunotherapy drug shows promise in large trial
Disease control OngoingThis study tested the drug pembrolizumab in over 1,600 people with various advanced solid tumors that had stopped responding to standard treatments. The goal was to see if the drug could shrink or control the tumors. The trial focused on identifying which patients were most likel…
Matched conditions: NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Promising drug shows potential to stall neuroendocrine tumors
Disease control OngoingThis study tests whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors (including carcinoid tumors) better than a placebo. About 298 adults whose cancer worsened after previous treatments will receive either cabozantinib or a dummy pill. The goal is …
Matched conditions: NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Major trial tests two drug cocktails for Hard-to-Treat carcinoid cancer
Disease control OngoingThis study compares two drug combinations for people with advanced neuroendocrine tumors (carcinoid cancer) that cannot be removed by surgery. Participants receive either octreotide plus interferon or octreotide plus bevacizumab. The goal is to see which combination better delays…
Matched conditions: NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New registry aims to unlock secrets of neuroendocrine tumors
Knowledge-focused ENROLLING_BY_INVITATIONThis study is creating a registry of 400 people with neuroendocrine tumors (NETs). Researchers will collect blood samples and health data over time to see if certain biomarkers can help detect tumors earlier, predict treatment response, and monitor for recurrence. The goal is to …
Matched conditions: NEUROENDOCRINE TUMOR
Sponsor: Wren Laboratories LLC • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC